Top Markets
Coin of the day
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc.

ALSE
株式のランク #42806
Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and... Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and therapeutic solutions, with a primary emphasis on ailments affecting the central nervous system. Their flagship experimental compound is Altropane, a molecular imaging agent developed for identifying and diagnosing Parkinson's disease and dementia. Founded in 1972, the company was previously known as Boston Life Sciences, Inc. before officially changing its name to Alseres Pharmaceuticals, Inc. in June 2007. Its operations are headquartered in Auburndale, Massachusetts.
株価
$0.01
最終同期: 2024-08-19
時価総額
$61.27
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Alseres Pharmaceuticals, Inc. (ALSE)

カテゴリー

Alseres Pharmaceuticals, Inc.(ALSE)の配当利回りの履歴
Alseres Pharmaceuticals, Inc.(銘柄コード: ALSE)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Alseres Pharmaceuticals, Inc.(ALSE)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)